Acelrx.com

Visit acelrx.com
  • 831.8K

    Global Rank

  • 6 days ago

    Last scanned

  • 19 years

    Domain Age

  • No data

    Daily Visitors

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

Optimizing outcomes in medically supervised settings | Talphera

Talphera is developing Niyad™, nafamostat, for renal replacement therapy in dialysis patients who cannot tolerate heparin or have an increased risk of bleeding

Acelrx.com thumbnail
Acelrx.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Vultr Holdings, LLC, which reserves the following IP addresses for acelrx.com: 149.28.220.224. Moreover, DNS used with this website include ns0.dnsmadeeasy.com, ns1.dnsmadeeasy.com, ns2.dnsmadeeasy.com, ns3.dnsmadeeasy.com, ns4.dnsmadeeasy.com. Subnet identifier ranges from 149.28.220.0 to 149.28.221.255. Classless Inter-Domain Routing (CIDR) is 149.28.220.0/23. ARIN net type is Reassigned.

  • 831.8K

    Global Rank

  • 6 days ago

    Last scanned

  • 19 years

    Domain Age

  • No data

    Daily Visitors

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of acelrx.com is REGISTER.COM, INC. and the name expires on 2025-02-04. Owner email is obscured for security reasons, so you cannot reach them directly. Their country of residence is United States of America.

  • pca
  • non-invasive
  • Analgesic
  • AcelRx Pharmaceuticals
  • Sufentanil
  • ARX-02
  • oral transmucosal delivery
  • acrx
  • acel rx

Websites similar to acelrx.com